Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
Nature, Published online: 23 April 2025; doi:10.1038/s41586-025-08917-zA study of human and mouse models of pancreatic cancer finds that inhibiting the lipid kinase PIKfyve interferes with the cancer’s lipid homeostasis, making it a potential target for drug development.

Nature, Published online: 23 April 2025; doi:10.1038/s41586-025-08917-zA study of human and mouse models of pancreatic cancer finds that inhibiting the lipid kinase PIKfyve interferes with the cancer’s lipid homeostasis, making it a potential target for drug development.